CY1108241T1 - Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας - Google Patents
Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειαςInfo
- Publication number
- CY1108241T1 CY1108241T1 CY20081100825T CY081100825T CY1108241T1 CY 1108241 T1 CY1108241 T1 CY 1108241T1 CY 20081100825 T CY20081100825 T CY 20081100825T CY 081100825 T CY081100825 T CY 081100825T CY 1108241 T1 CY1108241 T1 CY 1108241T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- pyridylsulfonamide
- pyrimidines
- kidney disease
- diabetic kidney
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με την χρήση μιας ένωσης του χημικού τύπου (I) όπου το R1 είναι πυριδυλ ή θειαζολυλ, καθένα από τα οποία μπορεί επιλεκτικά να υποκατασταθεί από C1-8 αλκυλ ή C2-8 αλκενυλ · και α) το R2 είναι μεθοξύ και το n είναι μηδέν ή ένα · ή β) το R2 είναι χλώριο και το n είναι μηδέν και φαρμακευτικώς αποδεκτά άλατα αυτού για την μείωση ή τον έλεγχο της πρωτεϊνουρίας, και συγκεκριμένα για την θεραπεία της διαβητικής νεφροπάθειας.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03100549A EP1454625A1 (en) | 2003-03-06 | 2003-03-06 | Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies |
| EP04716605A EP1601361B1 (en) | 2003-03-06 | 2004-03-03 | Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108241T1 true CY1108241T1 (el) | 2013-09-04 |
Family
ID=32799012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100825T CY1108241T1 (el) | 2003-03-06 | 2008-08-06 | Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US20060094731A1 (el) |
| EP (2) | EP1454625A1 (el) |
| JP (1) | JP4737686B2 (el) |
| KR (1) | KR101099189B1 (el) |
| CN (1) | CN100453081C (el) |
| AT (1) | ATE395063T1 (el) |
| AU (2) | AU2004216858B2 (el) |
| BR (1) | BRPI0408082A (el) |
| CA (1) | CA2517930C (el) |
| CY (1) | CY1108241T1 (el) |
| DE (1) | DE602004013734D1 (el) |
| DK (1) | DK1601361T3 (el) |
| EC (1) | ECSP056060A (el) |
| ES (1) | ES2305737T3 (el) |
| HK (1) | HK1083761A1 (el) |
| HR (1) | HRP20050860A2 (el) |
| IL (1) | IL170626A (el) |
| MX (1) | MXPA05009478A (el) |
| NO (1) | NO20054148L (el) |
| NZ (1) | NZ542155A (el) |
| PL (1) | PL1601361T3 (el) |
| PT (1) | PT1601361E (el) |
| RS (1) | RS20050683A (el) |
| SI (1) | SI1601361T1 (el) |
| UA (1) | UA82087C2 (el) |
| WO (1) | WO2004078104A2 (el) |
| ZA (1) | ZA200507122B (el) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1595880A1 (en) * | 2004-05-13 | 2005-11-16 | Speedel Pharma AG | Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists |
| BRPI0615794A2 (pt) * | 2005-09-12 | 2011-05-24 | Speedel Pharma Ag | piridilsulfonamidil-pirimidinas para a prevenção de falha de enxerto de vaso sangüìneo |
| KR101967868B1 (ko) | 2010-06-17 | 2019-08-19 | 닛토덴코 가부시키가이샤 | 신장 섬유증 치료 물질 |
| CN109260164A (zh) * | 2018-10-07 | 2019-01-25 | 威海贯标信息科技有限公司 | 一种阿伏生坦片剂组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL316259A1 (en) * | 1994-03-17 | 1997-01-06 | Ciba Geigy Ag | Treatment of diabetic nephropathy with valsartan |
| CA2162630C (en) * | 1994-11-25 | 2007-05-01 | Volker Breu | Sulfonamides |
| DE69626986T2 (de) * | 1995-08-02 | 2004-02-05 | Smithkline Beecham Corp. | Endothelinrezeptorantagonist |
| US6417360B1 (en) * | 1999-03-03 | 2002-07-09 | Hoffmann-La Roche Inc. | Heterocyclic sulfonamides |
| AU2001263850A1 (en) * | 2000-04-20 | 2001-11-07 | Actelion Pharmaceuticals Ltd | Pyrimidine-sulfonamides having endothelin-antagonist activity |
-
2003
- 2003-03-06 EP EP03100549A patent/EP1454625A1/en not_active Withdrawn
-
2004
- 2004-03-03 BR BRPI0408082-3A patent/BRPI0408082A/pt not_active IP Right Cessation
- 2004-03-03 RS YUP-2005/0683A patent/RS20050683A/sr unknown
- 2004-03-03 CN CNB2004800058469A patent/CN100453081C/zh not_active Expired - Fee Related
- 2004-03-03 US US10/548,080 patent/US20060094731A1/en not_active Abandoned
- 2004-03-03 JP JP2006505443A patent/JP4737686B2/ja not_active Expired - Fee Related
- 2004-03-03 ES ES04716605T patent/ES2305737T3/es not_active Expired - Lifetime
- 2004-03-03 MX MXPA05009478A patent/MXPA05009478A/es active IP Right Grant
- 2004-03-03 WO PCT/EP2004/050242 patent/WO2004078104A2/en active IP Right Grant
- 2004-03-03 SI SI200430798T patent/SI1601361T1/sl unknown
- 2004-03-03 CA CA2517930A patent/CA2517930C/en not_active Expired - Fee Related
- 2004-03-03 PL PL04716605T patent/PL1601361T3/pl unknown
- 2004-03-03 DE DE602004013734T patent/DE602004013734D1/de not_active Expired - Lifetime
- 2004-03-03 UA UAA200509348A patent/UA82087C2/uk unknown
- 2004-03-03 EP EP04716605A patent/EP1601361B1/en not_active Expired - Lifetime
- 2004-03-03 AU AU2004216858A patent/AU2004216858B2/en not_active Ceased
- 2004-03-03 NZ NZ542155A patent/NZ542155A/en not_active IP Right Cessation
- 2004-03-03 DK DK04716605T patent/DK1601361T3/da active
- 2004-03-03 KR KR1020057016511A patent/KR101099189B1/ko not_active IP Right Cessation
- 2004-03-03 AT AT04716605T patent/ATE395063T1/de active
- 2004-03-03 PT PT04716605T patent/PT1601361E/pt unknown
-
2005
- 2005-09-01 IL IL170626A patent/IL170626A/en not_active IP Right Cessation
- 2005-09-05 ZA ZA200507122A patent/ZA200507122B/en unknown
- 2005-09-06 NO NO20054148A patent/NO20054148L/no not_active Application Discontinuation
- 2005-09-28 HR HR20050860A patent/HRP20050860A2/hr not_active Application Discontinuation
- 2005-09-29 EC EC2005006060A patent/ECSP056060A/es unknown
-
2006
- 2006-03-30 HK HK06103985A patent/HK1083761A1/xx not_active IP Right Cessation
-
2008
- 2008-07-28 US US12/219,751 patent/US20090005404A1/en not_active Abandoned
- 2008-08-06 CY CY20081100825T patent/CY1108241T1/el unknown
-
2009
- 2009-10-14 AU AU2009225323A patent/AU2009225323B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE540928T1 (de) | Isochinolinverbindungen und ihre medizinische verwendung | |
| DK1940786T3 (da) | Biphenylderivater og deres anvendelse ved behandling af hepatitis C | |
| DK1855677T3 (da) | 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser | |
| DE60330757D1 (de) | Verwendung von pyridylamiden als angiogenesehemmer | |
| EA200600928A1 (ru) | Фармацевтически приемлемые соли хинолиноновых соединений с улучшенными фармацевтическими свойствами | |
| NO20052796L (no) | Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese | |
| DE60230266D1 (de) | Phenylpyridincarbonyl piperazinderivate | |
| ATE418548T1 (de) | Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten | |
| NO20080265L (no) | 2-(1H-indolylsulfanyl)-arylaminderivater | |
| ATE399161T1 (de) | 7-(2-(4-(3-trifluormethylphenyl)-1,2,3,6- tetrahydropyrid-1-yl)ethyl)isochinolin- besylatsalz, dessen herstellung und dessen therapeutische verwendung | |
| NO20055632L (no) | Aromatiske oksyfenyl- og aromatiske sulfanylfenylderivater | |
| BRPI0607214A2 (pt) | derivados de 2-(4-cianofenilamino) pirimidina inibidores de hiv | |
| CY1108241T1 (el) | Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας | |
| EA200800151A1 (ru) | Производные хинолина в качестве антибактериальных агентов | |
| GB0412314D0 (en) | Compounds | |
| ATE297902T1 (de) | Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren | |
| NO20016402L (no) | Trisykliske forbindelser med spiro-kobling | |
| ATE425162T1 (de) | Thiazolderivate als npy-antagonisten | |
| DK1924255T3 (da) | Anvendelse af N-(dibenz(B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamin (OMIGAPIL) til profylakse og/eller behandling af muskeldystrofi | |
| ATE338046T1 (de) | 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza- cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität | |
| TH82384A (th) | อนุพันธ์แอริล 1,4-ไพราซินที่ถูกแทนที่ | |
| AR052553A1 (es) | Derivados de benzoil -tetrahidropiridina | |
| ATE338759T1 (de) | 2-(aminomethyl)tetrahydro-9-oxa-1,3- diazacyclopentaca)naphthalinylderivate mit antipsychotischer wirkung | |
| TH82336B (th) | สารยับยั้ง n-ซับสติติวเต็ดไพราโซลิล-อะมิดิล-เบนซิมิดาโซลิล c-kit | |
| TH79975A (th) | ยาเพื่อการรักษาหรือการป้องกันโรคภาวะพังผืด |